Van Eck Associates Corp Astrazeneca PLC Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Van Eck Associates Corp holds 444,792 shares of AZN stock, worth $29.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

444,792

Previous 377,790 17.74%

Holding current value

$29.7 Million

Previous $29.5 Million 16.17%

% of portfolio

0.04%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$76.67 - $87.62 $5.14 Million - $5.87 Million	67,002 Added 17.74%	444,792 $34.2 Million
Q2 2024 Jul 31, 2024	SELL	$66.81 - $80.83 $2.91 Million - $3.52 Million	-43,520 Reduced 10.33%	377,790 $29.5 Million
Q1 2024 Apr 30, 2024	BUY	$61.03 - $69.57 $6.03 Million - $6.88 Million	98,836 Added 30.65%	421,310 $28.5 Million
Q4 2023 Feb 05, 2024	BUY	$61.89 - $69.28 $54,772 - $61,312	885 Added 0.28%	322,474 $21.7 Million
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $4.23 Million - $4.67 Million	65,154 Added 25.41%	321,589 $21.8 Million
Q2 2023 Aug 03, 2023	SELL	$69.91 - $75.81 $1.58 Million - $1.71 Million	-22,554 Reduced 8.08%	256,435 $18.4 Million
Q1 2023 May 03, 2023	SELL	$63.15 - $71.6 $9.11 Million - $10.3 Million	-144,229 Reduced 34.08%	278,989 $19.4 Million
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $2.01 Million - $2.61 Million	-37,118 Reduced 8.06%	423,218 $28.7 Million
Q3 2022 Oct 27, 2022	SELL	$53.02 - $135.75 $152,591 - $390,688	-2,878 Reduced 0.62%	460,336 $25.2 Million
Q2 2022 Aug 03, 2022	BUY	$59.26 - $71.14 $9.76 Million - $11.7 Million	164,741 Added 55.19%	463,214 $30.6 Million
Q1 2022 May 10, 2022	SELL	$55.72 - $67.12 $1.27 Million - $1.53 Million	-22,742 Reduced 7.08%	298,473 $19.8 Million
Q4 2021 Jan 26, 2022	BUY	$54.02 - $63.83 $1.62 Million - $1.92 Million	30,009 Added 10.31%	321,215 $18.7 Million
Q3 2021 Nov 03, 2021	BUY	$55.56 - $60.79 $4.04 Million - $4.42 Million	72,745 Added 33.3%	291,206 $17.5 Million
Q2 2021 Aug 10, 2021	SELL	$48.42 - $60.18 $1.3 Million - $1.62 Million	-26,936 Reduced 10.98%	218,461 $13.1 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $582,190 - $672,061	12,345 Added 5.3%	245,397 $12.2 Million
Q4 2020 Feb 09, 2021	BUY	$48.52 - $58.02 $622,074 - $743,874	12,821 Added 5.82%	233,052 $11.7 Million
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $16,292 - $18,757	307 Added 0.14%	220,231 $12.1 Million
Q2 2020 Aug 10, 2020	BUY	$43.1 - $55.31 $486,254 - $624,007	11,282 Added 5.41%	219,924 $11.6 Million
Q1 2020 May 12, 2020	BUY	$37.79 - $51.33 $135,703 - $184,326	3,591 Added 1.75%	208,642 $9.32 Million
Q4 2019 Feb 13, 2020	BUY	$42.46 - $50.46 $1.6 Million - $1.9 Million	37,749 Added 22.56%	205,051 $10.2 Million
Q3 2019 Nov 08, 2019	SELL	$40.12 - $45.47 $1.92 Million - $2.18 Million	-47,863 Reduced 22.24%	167,302 $7.46 Million
Q2 2019 Aug 07, 2019	SELL	$37.28 - $41.68 $237,622 - $265,668	-6,374 Reduced 2.88%	215,165 $8.88 Million
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $3.51 Million - $4.25 Million	-98,813 Reduced 30.85%	221,539 $8.96 Million
Q4 2018 Feb 12, 2019	SELL	$36.86 - $41.49 $1.31 Million - $1.47 Million	-35,485 Reduced 9.97%	320,352 $12.2 Million
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $889,299 - $1.02 Million	-25,584 Reduced 6.71%	355,837 $14.1 Million
Q2 2018 Aug 13, 2018	BUY	$34.55 - $37.05 $346,536 - $371,611	10,030 Added 2.7%	381,421 $13.4 Million
Q1 2018 May 11, 2018	SELL	$32.97 - $36.63 $1.58 Million - $1.75 Million	-47,799 Reduced 11.4%	371,391 $13 Million
Q4 2017 Feb 12, 2018	SELL	$32.09 - $34.78 $1.08 Million - $1.17 Million	-33,636 Reduced 7.43%	419,190 $14.5 Million
Q3 2017 Nov 09, 2017	BUY	$28.96 - $34.0 $1.73 Million - $2.03 Million	59,615 Added 15.16%	452,826 $15.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	393,211	393,211 $13.4 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $207B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Astrazeneca PLC Transaction History